MedPath

Prospective study on the usefulness of K-2S plus as as enteral nutrients after pancreatoduodenectomy

Not Applicable
Recruiting
Conditions
Patients who undergo pancreatoduodenectomy for peri-pancreatic tumors such as pancreatic cancers or lower bile duct cancers
Registration Number
JPRN-UMIN000036511
Lead Sponsor
Kumamoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who are contraindicated with K-2S plus or Erental 1) A case with allergies to eggs, dairy products and soy 2) A case with hypersensitivity to K-2S plus 3) A case with hypersensitivity to Ellenthal 4) A case with amino acid metabolism disorder (2) Cases with active bacterial and fungal infections (cases with fever above 38 degree and cases where bacterial infection has been shown by imaging or bacteriological examination). (3) A case that is complicated by psychosis or psychiatric symptoms and difficult to participate in this study. (4) Cases that the study responsible (share) physician judged inappropriate for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath